Self-administration of cocaine-opioid combinations by rhesus monkeys: Evaluation of the role of μ receptor efficacy using labor supply analysis

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 3, 2005, Pages 1289-1297

  Rowlett, James K ^a   Rodefer, Joshua S ^a,b   Spealman, Roger D ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

^b E11 SSH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALFENTANIL; COCAINE; DIAMORPHINE; MU OPIATE RECEPTOR; NALBUPHINE; OPIATE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ABUSE; DRUG COST; DRUG EFFICACY; DRUG MEGADOSE; DRUG SELF ADMINISTRATION; DRUG USE; FEMALE; HEALTH ECONOMICS; INCOME; MALE; NONHUMAN; PRIORITY JOURNAL; REINFORCEMENT; RHESUS MONKEY; THEORETICAL MODEL;

ALFENTANIL; ANIMALS; BEHAVIOR, ANIMAL; COCAINE; FEMALE; HEROIN; MACACA MULATTA; MALE; MODELS, ECONOMIC; NALBUPHINE; NARCOTICS; RECEPTORS, OPIOID, MU; REINFORCEMENT (PSYCHOLOGY); SELF ADMINISTRATION;

EID: 14344263111     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.076646     Document Type: Article

References (26)

1. Allison J (1983) Behavioral Economics, Praeger, New York.
2. Allison J (1993) Response deprivation, reinforcement and economics. J Exp Anal Behav 60:129-140.
3. Brooner EK, King VL, Kidorf M, Schmidt CW, and Bigelow GE (1997) Psychiatric and substance use comorbidity among treatment-seeking opioid abusers. Arch Gen Psychiatry 54:71-80.
4. Carey GJ and Spealman RD (1998) CNS-neurological models of disease: substance abuse/self-administration, in Current Protocols in Pharmacology (Enna S, Williams M, Ferkany J, Kenakin T, Porsolt R, and Sullivan J eds) pp 10.5.1-10.5.15, John Wiley and Sons, New York.
5. Di Chiara G and North RA (1992) Neurobiology of opiate abuse. Trends Pharmacol Sci 13:185-193.
6. Dykstra LA, Preston KL, and Bigelow GE (1997) Discriminative stimulus and subjective effects of opioids with mu and kappa activity: data from laboratory animals and human subjects. Psychopharmacology 130:14-27.
7. Gerak LR, Butelman ER, Woods JH, and France CP (1994) Antinociceptive and respiratory effects of nalbuphine in rhesus monkeys. J Pharmacol Exp Ther 271:993-999.
8. Hemby SE, Co C, Dworkin SI, and Smith JE (1999) Synergistic elevations in nucleus accumbens extracellular dopamine concentrations during self-administration of cocaine/heroin combinations (speedball) in rats. J Pharmacol Exp Ther 288:274-280.
9. Koob GF and Bloom FE (1988) Cellular and molecular mechanisms of drug dependence. Science (Wash DC) 242:715-723.
10. Kosten TR, Rounsaville BJ, Gawin FH, and Kleber HD (1986) Cocaine abuse among opioid addicts: demographic and diagnostic factors in treatment. Am J Drug Alcohol Abuse 12:1-16.
11. Leri F, Bruneau J, and Stewart J (2003) Understanding polydrug use: review of heroin and cocaine co-use. Addiction 98:7-22.
12. Mello NK and Negus SS (1999) Effects of flupenthixol and quadazocine on self-administration of speedball combinations of cocaine and heroin by rhesus monkeys. Neuropsychopharmacology 21:575-588.
13. Mello NK, Negus SS, Lukas SE, Mendelson JH, Sholar JW, and Drieze J (1995) A primate model of polydrug abuse: cocaine and heroin combinations. J Pharmacol Exp Ther 274:1325-1337.
14. Negus SS, Gatch MB, and Mello NK (1998) Effects of mu opioid agonists alone and in combination with cocaine and d-amphetamine in rhesus monkeys trained to discriminate cocaine. Neuropsychopharmacology 18:325-338.
15. Rowlett JK (2000) A labor-supply analysis of cocaine self-administration under progressive-ratio schedules: antecedents, methodologies and perspectives. Psychopharmacology 153:1-16.
16. Rowlett JK, Massey BW, Kleven MS, and Woolverton WL (1996) Parametric analysis of cocaine self-administration under a progressive-ratio schedule in rhesus monkeys. Psychopharmacology 125:361-370.
17. Rowlett JK, Negus SS, Shippenberg TS, Mello NK, Walsh SL and Spealman RD (1998a) Combined cocaine and opioid abuse: from neurobiology to the clinic, in NIDA Research Monograph 178 (Harris LS ed) pp 55-57, U.S. Government Printing Office, Washington, DC.
18. Rowlett JK, Rodefer JS, and Spealman RD (2002) Self-administration of cocaine, alfentanil and nalbuphine under progressive-ratio schedules: consumer demand and labor supply analyses of relative reinforcing effectiveness. Exp Clin Psychopharmacol 10:367-375.
19. Rowlett JK and Woolverton WL (1997) Self-administration of cocaine and heroin combinations by rhesus monkeys responding under a progressive-ratio schedule. Psychopharmacology 133:363-371.
20. Rowlett JK, Wilcox KM, and Woolverton WL (1998b) Self-administration of cocaine-heroin combinations by rhesus monkeys: antagonism by naltrexone. J Pharmacol Exp Ther 286:61-69.
21. Smith MA, Gordon KA, Craig CK, Bryant PA, Ferguson ME, French AM, Gray JD, McClean JM, and Tetirick JC (2003) Interactions between opioids and cocaine on locomotor activity in rats: influence of an opioid's relative efficacy at the mu receptor. Psychopharmacology 167:265-273.
22. Walker EA, Butelman ER, DeCosta BR, and Woods JH (1993) Opioid thermal antinociception in rhesus monkeys: receptor mechanisms and temperature dependency. J Pharmacol Exp Ther 267:280-286.
23. Wines JD, Gruber AJ, Pope HG, and Lukas SE (1999) Nalbuphine hydrochloride dependence in anabolic steroid users. Am J Addict 8:161-164.
24. Winger G, Woods JH, and Hursh SR (1996) Behavior maintained by alfentanil or nalbuphine in rhesus monkeys: fixed-ratio and time-out changes to establish demand curves and relative reinforcing effectiveness. Exp Clin Psychopharmacol 4:131-140.
25. 2 analysis in assessment of opioid abuse liability. Trends Pharmacol Sci 13:282-286.
26. Zernig G, Lewis JW, and Woods JH (1997) Clocinnamox inhibits the intravenous self-administration of opioid agonists in rhesus monkeys: comparison with effects on opioid agonist-mediated antinociception. Psychopharmacology 129:233-242.